Table 4.
Trial subject area | Number | Percentage |
---|---|---|
Oncology/haematology – cancer | 142 | 20 |
Neurology – neurodegenerative diseases, vascular Diseases | 93 | 13 |
Cardiovascular diseases | 44 | 6 |
Mental health | 42 | 6 |
Metabolism – diabetes mellitus | 38 | 5 |
Orthopaedics/musculoskeletal | 34 | 5 |
Reproductive Health | 34 | 5 |
Gastroenterology – hepatology, nephrology | 29 | 4 |
Paediatrics/neonates | 22 | 3 |
Respiratory | 20 | 3 |
Inflammatory conditions (e.g. osteoarthritis, rheumatoid arthritis, fibromyalgia) | 15 | 2 |
Surgery | 15 | 2 |
Ophthalmology | 14 | 2 |
Vaccines – preventive vaccines | 13 | 2 |
Dementia/ageing | 12 | 2 |
Infectious diseases | 9 | 1 |
Dermatology | 7 | 1 |
Palliative care | 4 | 1 |
Involved in multiple trials | 38 | 5 |
Other | 79 | 11 |
Totala | 704 | 100% |
aData were missing or response was “Do not know” in 86 respondents